GM-CSF and M-CSF driven differentiation differentially regulates Chikungunya virus infection and antiviral responses in human monocyte-derived macrophages
Chikungunya virus is an arthritogenic alphavirus causing debilitating joint pain in infected individuals. The mechanisms driving CHIKV-associated arthralgia is poorly understood, however, macrophages have been implicated as potential reservoirs of persistent viral material and mediators of immunopathology. Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) and Macrophage-Colony Stimulating Factor (M-CSF) are cytokines that serve as myeloid growth factors that bias macrophages toward pro-inflammatory and anti-inflammatory phenotypes, respectively. In this study, we examined how cytokine-driven macrophage differentiation via GM-CSF and M-CSF influences susceptibility to and responses against CHIKV infection in vitro. Using parallel donor-matched cultures of primary macrophages, we show that GM-CSF-differentiated macrophages are highly permissive to CHIKV and Mayaro virus (MAYV) infection and support robust viral replication, whereas M-CSF-differentiated macrophages are resistant to CHIKV replication and lack detectable levels of viral protein expression. Despite these differences, we observed pro-inflammatory, M1-skewing of CHIKV-infected macrophages, regardless of differentiation state. Interestingly, we observe higher production of IFNα and IP10/CXCL10 in M-CSF differentiated macrophages, suggesting that M-CSF promotes an antiviral state that restricts CHIKV infection. Stimulation of macrophages with double-stranded RNA (polyinosinic:polycytidylic acid; poly(I:C)), but not with single-stranded RNA (resiquimod, R848), recapitulated the antiviral cytokine and chemokine response induced by CHIKV infection. These findings suggest that dsRNA sensing plays a more prominent role than ssRNA sensing in driving the macrophage antiviral response to CHIKV. Together, these findings highlight macrophage differentiation as a critical determinant of CHIKV susceptibility and antiviral immunity in humans, with implications for understanding inflammatory pathogenesis during infection.
Authors
- Laura Espinar‐Barranco (ORCID: https://orcid.org/0000-0001-5371-8671)
- Sara A. Thannickal (ORCID: https://orcid.org/0000-0002-7028-3507)
- Vrushali Dhamapurkar
- Estefania Valencia (ORCID: https://orcid.org/0009-0009-8362-0558)
- Rafael Fenutría (ORCID: https://orcid.org/0000-0001-9119-934X)
- Eva Chebishev (ORCID: https://orcid.org/0000-0001-8860-2994)
- Maria Gabriela Noval (ORCID: https://orcid.org/0000-0002-9140-0565)
- Victoria Zyulina (ORCID: https://orcid.org/0000-0001-7329-8045)
- Jeury Veloz (ORCID: https://orcid.org/0000-0001-8281-0098)
- Laurence G. Webb (ORCID: https://orcid.org/0000-0001-8307-8492)
- Chenyang Wu (ORCID: https://orcid.org/0000-0002-8148-0207)
- Dabeiba Bernal‐Rubio (ORCID: https://orcid.org/0009-0006-9861-8256)
- Danielle Novillo (ORCID: https://orcid.org/0009-0002-6038-2437)
- Maria del Mar Villanueva Guzman (ORCID: https://orcid.org/0009-0006-9854-3864)
- Ana Fernandez-Sesma (ORCID: https://orcid.org/0000-0002-3405-6702)
Institutions
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- PLoS Pathogens
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1371/journal.ppat.1014773
- Primary Topic
- Mosquito-borne diseases and control
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases